Found 13 matching trials
Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases
PHASE3RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Location
Kyoto University Hospital
Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.
PHASE2Multi-centre one year trial for patients who have rising PSA while on Casod...
Location
Sunnybrook Health Sciences Centre
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
PHASE4Androgen deprivation therapy (ADT) is a mainstay of prostate cancer treatme...
Location
Department of Urology, Chungbuk National University, College of Medicine
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1This study consists of a dose escalation study with an expansion phase to e...
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
PHASE3This study addresses the global topic of treatment optimization, i.e. achie...
Location
University Hospitals Copenhagen - Rigshospitalet
A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
PHASE1This study will test the safety and efficacy of FOR46 given every 21 days t...
Location
UCLA Institute of Urologic Oncology
CMAB vs IMAB in Metastatic Prostate Cancer
PHASE4To evaluate the efficacy, safety and survival of two treatment regimens: Co...
Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer
N/AThis is a biopsy feasibility study in which patients with castration resist...
Location
The Christie NHS Foundation Trust
Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.
PHASE2Open-label phase II multi-centre single arm study of Denosumab in combinati...
Location
Galway University Hospital
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
PHASE1This clinical study is aiming to determine the safest doses and schedule fo...
Status
Active Not Recruiting
Location
The Christie NHS Foundation Trust